Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR TKIs in non-small-cell lung carcinoma

被引：0
|
作者：
Kim, H. [1 ]
Lee, S. Y. [1 ]
Choi, Y. J. [1 ]
Kim, J. S. [1 ]
Kim, S. T. [1 ]
Park, K. H. [1 ]
Shin, S. W. [1 ]
Kim, Y. H. [1 ]
机构：
[1] Korea Univ, Anam Hosp, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
704
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [21] Therapeutic efficacy comparison of six major EGFR-TKIs in non-small-cell lung cancer patients with an activating EGFR mutation: A network meta-analysis.
    Wu, Fang
    He, Jingyi
    Wu, Sixuan
    Huang, Yan
    Li, Yizheng
    Zhao, Lishu
    Hu, Chunhong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Next-Generation Sequencing Reveals High Uncommon EGFR Mutations and Tumour Mutation Burden in a Subgroup of Lung Cancer Patients
    Guo, Gang
    Li, Gaofeng
    Liu, Yinqiang
    Li, Heng
    Guo, Qi
    Liu, Jun
    Yang, Xiumei
    Shou, Tao
    Shi, Yunfei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Neoadjuvant EGFR TKIs: toward personalized management in non-small-cell lung cancer
    Passaro, Antonio
    Cortesi, Enrico
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (04) : 280 - 282
  • [24] Future prospects of EGFR-TKIs and surgery for non-small-cell lung cancer
    Nagano, Tatsuya
    Tachihara, Motoko
    Tanaka, Yugo
    JOURNAL OF THORACIC DISEASE, 2022, 14 (04) : 809 - 811
  • [25] Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer
    Hitij, Nina Turnsek
    Kern, Izidor
    Sadikov, Aleksander
    Knez, Lea
    Stanic, Karmen
    Zwitter, Matjaz
    Cufer, Tanja
    CLINICAL LUNG CANCER, 2017, 18 (03) : E187 - E196
  • [26] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [27] Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer
    Ying-Qiang Lu
    Kai-Hua Lu
    慢性疾病与转化医学（英文）, 2017, 3 (01) : 1 - 7
  • [28] Comparison of efficacy and safety of second- and third-generation TKIs for non-small-cell lung cancer with uncommon EGFR mutations
    Hao, Yue
    Xu, Manyi
    Jin, Jianan
    Si, Jinfei
    Xu, Chunwei
    Song, Zhengbo
    CANCER MEDICINE, 2023, 12 (15): : 15903 - 15911
  • [29] Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients
    Fuchs, Vered
    Kian, Waleed
    Lichtenberg, Rachel
    Cooper, Jonah M.
    Remilah, Areen A.
    Levin, Daniel
    Peled, Nir
    Roisman, Laila C.
    CLINICAL DRUG INVESTIGATION, 2022, 42 (02) : 185 - 192
  • [30] Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients
    Vered Fuchs
    Waleed Kian
    Rachel Lichtenberg
    Jonah M. Cooper
    Areen A. Remilah
    Daniel Levin
    Nir Peled
    Laila C. Roisman
    Clinical Drug Investigation, 2022, 42 : 185 - 192
12345